Ahmet Oğuz Çelik
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ahmet Oğuz Çelik has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Bilger Çavuş
Division of Gastroenterohepatology, Department of Internal Medicine, Istanbul University Istanbul Faculty of Medicine, Istanbul, Turkiye
2 shared publications - Filiz Akyüz
Department of Gastroenterology, İstanbul University İstanbul Faculty of Medicine, İstanbul, Türkiye
2 shared publications - Zulal İsTemihan
Division of Gastroenterohepatology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Türkiye
2 shared publications - Arzu Taş
Istanbul University
1 shared publication - Aslı Çifcibaşı Örmeci
Division of Gastroenterohepatology, Department of Internal Medicine, Istanbul University Istanbul Faculty of Medicine, Istanbul, Turkiye
1 shared publication - Aynura Rustamzada
Istanbul University
1 shared publication
Latest Publications
- 15 May 2026
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 138 (4) , 479-486
Time of first diagnosis in liver cirrhosis: what has changed over time from etiology to stage of disease?
It was aimed to investigate the characteristics of cirrhosis etiology, stage at diagnosis, diagnostic methods, and complications with a 1-decade interval. The clinical and demographic characteristics of patients with cirrhosis at the time of diagnosis at a tertiary university hospital between 2005-2009 (first period) and 2019-2023 (second period) were retrospectively investigated. In total, 1311 patients were diagnosed with cirrhosis, of which 857 (65.4%) were men. Seven hundred and ninety-eight (60.9%) were diagnosed in the first period. Six hundred and ninety (52.6%) patients were decompensated at diagnosis. Child Turcotte Pugh score was more common in the second period. MELD-Na score was higher in the first period (p = 0.026). The presentation rate with decompensation was higher in the first period (p = 0.009). In the first period, 211 (26.4%), and in the second period, 134 (26.1%) patients were diagnosed in the emergency department. The others were diagnosed in the outpatient clinic. There was no difference in the conditions for diagnosing between periods (p = 0.898). The causes of cirrhosis were, in order, 22.6% HBV, 19.7% MASLD, 18.9% cryptogenic, 13.1% ALD, 10.1% HCV, 7.7% autoimmune liver diseases, 4% HDV, 2.1% other causes, and 1.8% genetic diseases. In the second period, the frequency of cirrhosis caused by viral etiologies decreased (p < 0.05), and the frequency of MASLD and ALD increased (p < 0.05). Over the past decade, viral factors in the etiology of cirrhosis have gradually decreased, MASLD and ALD have progressively increased. While patients were detected more in compensated states, a significant portion of patients are still diagnosed in the decompensated stage and in emergency clinics.
- 15 May 2026
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 138 (4) , 479-486
Time of first diagnosis in liver cirrhosis: what has changed over time from etiology to stage of disease?
It was aimed to investigate the characteristics of cirrhosis etiology, stage at diagnosis, diagnostic methods, and complications with a 1-decade interval. The clinical and demographic characteristics of patients with cirrhosis at the time of diagnosis at a tertiary university hospital between 2005-2009 (first period) and 2019-2023 (second period) were retrospectively investigated. In total, 1311 patients were diagnosed with cirrhosis, of which 857 (65.4%) were men. Seven hundred and ninety-eight (60.9%) were diagnosed in the first period. Six hundred and ninety (52.6%) patients were decompensated at diagnosis. Child Turcotte Pugh score was more common in the second period. MELD-Na score was higher in the first period (p = 0.026). The presentation rate with decompensation was higher in the first period (p = 0.009). In the first period, 211 (26.4%), and in the second period, 134 (26.1%) patients were diagnosed in the emergency department. The others were diagnosed in the outpatient clinic. There was no difference in the conditions for diagnosing between periods (p = 0.898). The causes of cirrhosis were, in order, 22.6% HBV, 19.7% MASLD, 18.9% cryptogenic, 13.1% ALD, 10.1% HCV, 7.7% autoimmune liver diseases, 4% HDV, 2.1% other causes, and 1.8% genetic diseases. In the second period, the frequency of cirrhosis caused by viral etiologies decreased (p < 0.05), and the frequency of MASLD and ALD increased (p < 0.05). Over the past decade, viral factors in the etiology of cirrhosis have gradually decreased, MASLD and ALD have progressively increased. While patients were detected more in compensated states, a significant portion of patients are still diagnosed in the decompensated stage and in emergency clinics.
- Open Access
- 22 December 2025
- Published by Kare Publishing in Journal of Enterocolitis
A Rare and Overlooked Cause of Chronic Diarrhea: Hereditary Transthyretin Amyloidosis
Hereditary transthyretin amyloidosis is a rare, rapidly progressive, and fatal disease caused by pathogenic variants in the transthyretin gene. It is inherited in an autosomal dominant manner. The disease is characterized by the accumulation of amyloid fibrils in various organs, particularly the peripheral nerves, heart, kidneys, eyes, and gastrointestinal tract. We present a rare case of transthyretin amyloidosis manifested by chronic diarrhea.
- 22 December 2025
- Published by Kare Publishing in Journal of Enterocolitis
Open AccessA Rare and Overlooked Cause of Chronic Diarrhea: Hereditary Transthyretin Amyloidosis
Hereditary transthyretin amyloidosis is a rare, rapidly progressive, and fatal disease caused by pathogenic variants in the transthyretin gene. It is inherited in an autosomal dominant manner. The disease is characterized by the accumulation of amyloid fibrils in various organs, particularly the peripheral nerves, heart, kidneys, eyes, and gastrointestinal tract. We present a rare case of transthyretin amyloidosis manifested by chronic diarrhea.